Florida regulates compounding pharmacies and outsourcing facilities through its own permit system, layered on top of FDA oversight. A Florida-permitted pharmacy compounding sterile products under 503A needs one state permit. A 503B outsourcing facility shipping into Florida needs a different one, and FDA registration substitutes for neither. Every permit name, application requirement, and fee below comes from the Florida Board of Pharmacy and the Florida Department of Health as published on the date of this writing. Holding the wrong permit, or none, risks Department of Health discipline and the loss of shipping privileges into the state.
The Permit That Authorizes Sterile Compounding
A Florida-permitted pharmacy that compounds sterile products under 503A, whether for a specific patient or in office-use quantities, must hold a Special Sterile Compounding Permit on top of its underlying community, institutional, or special pharmacy permit. The Board of Pharmacy issues the permit under the special-pharmacy-permit statute, Fla. Stat. 465.0196, and the current rule, Florida Administrative Code 64B16-28.802, sets the specific standards. Policies and procedures must meet USP Chapter 797 sterile and hazardous compounding standards, including the beyond-use dating practices a frequent audit flashpoint. The pharmacist in charge answers for the compounding area's security and records.
How Florida Treats 503B Outsourcing Facilities
Florida defines an outsourcing facility as a single physical location registered under the federal Drug Quality and Security Act where sterile compounding occurs. That federal registration covers cGMP compliance and FDA inspection. It does not, by itself, authorize the facility's compounding activity inside Florida or its shipments into the state, which still run through a Florida permit. The rule governing the Special Sterile Compounding Permit is titled to cover pharmacies and outsourcing facilities together, and Florida's nonresident-permit statute reaches an outsourcing facility without limiting that category to businesses located outside the state.
Nonresident Permits for Out-of-State Compounders Shipping Into Florida
An out-of-state pharmacy or outsourcing facility cannot ship, mail, deliver, or dispense a compounded sterile product into Florida without first holding a Nonresident Sterile Compounding Permit under Fla. Stat. 465.0158. The application calls for proof of FDA registration or a home-state license, written attestations from an owner and the pharmacist in charge, USP 797 policies and procedures, and a current inspection report. The Board of Pharmacy's own permit page lists the application fee at $255 ($250 plus a $5 unlicensed-activity fee), though the figure should be confirmed before filing since the board can adjust it by rule. A permit holder that ships a product compounded in violation of its home jurisdiction's rules can have the Florida permit denied, suspended, or revoked.
Department of Health Inspection Authority
The Department of Health's Board of Pharmacy inspects Florida pharmacies before issuing most permits. The Nonresident Sterile Compounding Permit works differently: an applicant submits a current inspection report, no older than six months for an initial application or one year for a renewal, from the regulatory or licensing agency where it operates. When that report is unavailable, the Department of Health can conduct its own onsite inspection, contract with an approved entity, or accept a report from the FDA for a registered outsourcing facility, at the applicant's expense. The board can also deny, suspend, revoke, fine, or reprimand a permit holder for noncompliance.
State Permits and FDA Outsourcing-Facility Registration
Registering with the FDA as a 503B outsourcing facility is a federal act that runs on its own registration and inspection cycle, separate from anything the Board of Pharmacy issues. A pharmacy compounding under 503A needs the Special Sterile Compounding Permit described above. A facility compounding under 503B and shipping into Florida, wherever it sits, needs the Nonresident Sterile Compounding Permit instead, and the two tracks can overlap for an operation running both a 503A pharmacy and a 503B outsourcing facility under one roof.
A federal 503B registration governs a facility's standing with the FDA, and shipping or dispensing in Florida still needs the separate permit that Florida law imposes.
Why Early Legal Counsel Is Critical
It is critical that compounding pharmacies and outsourcing facilities promptly retain experienced healthcare defense counsel when a Department of Health inspection turns up a finding, when a permit application is questioned, or when the board opens a disciplinary inquiry tied to sterile compounding. Early legal intervention can protect the pharmacy's rights, shape the record before an inspection finding becomes a permit denial or suspension, avoid inadvertent admissions during the inspection process, and allow counsel to communicate with the Department of Health on the pharmacy's behalf. Delaying representation can turn a correctable gap into a permit action.
How Health Law Alliance Can Help
Health Law Alliance has represented 2,500+ clients nationwide. If your pharmacy or facility is applying for a Special Sterile Compounding Permit or a Nonresident Sterile Compounding Permit, or has received a Department of Health inspection finding, contact Health Law Alliance's compounding pharmacy attorneys for a free, confidential consultation before a correctable issue becomes a permit action.
